市場調査レポート

商品コード

1801129

胃内バルーン市場：2025～2033年：製品、充填材料、インプラント手術、用途、エンドユーザー、地域別市場規模、シェア、動向、予測

Intragastric Balloons Market Size, Share, Trends and Forecast by Product, Filling Material, Implanting Procedure, Application, End-User, and Region, 2025-2033

出版日: 2025年08月01日
発行: IMARC
ページ情報: 英文 137 Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF & Excel (Single User License)

USD 2,999 444,961円

レポートPDFおよびExcelを1名のみがご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピー&ペースト、印刷はできません。

PDF & Excel (5 User License)

USD 3,999 593,331円

レポートPDFおよびExcelを同一企業内の5名様までがご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピー&ペーストはできませんが、印刷は5部まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Corporate License)

USD 4,999 741,701円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピー&ペーストは可能ですが、事前にIMARC Services Private Limited社の許可が必要です。PDFおよびExcelの印刷回数に制限はありません。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=148.37円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

胃内バルーンの世界市場規模は2024年に7,019万米ドルとなりました。今後、IMARC Groupは、市場は2033年までに1億6,963万米ドルに達し、2025～2033年のCAGRは9.79%になると予測しています。2024年の市場は北米が支配的でした。肥満率の高さ、ヘルスケアの先進性、FDAの早期承認、非外科的減量に対する需要の高まりなどが、胃内バルーン市場シェアの一因となっています。

同市場は、世界の肥満率の増加や体重超過に関連する健康上の懸念の高まりによって牽引力を増しています。バルーンは非外科的で一時的な減量ソリューションを提供するため、侵襲的な処置に代わるものを求める患者にとって魅力的です。デジタルヘルスキャンペーンや医療提供者による推奨を通じて認知度が高まっていることも、需要をさらに押し上げています。嚥下可能なバルーン、ガス充填バルーン、調節可能なバルーンなどの技術的改良は、患者の快適性を高め、対象者を拡大しています。さらに、一部の国における保険施策の支援や、特に手頃な価格で内視鏡手術を提供する地域における医療ツーリズムの成長が、採用を促進しています。また、新市場における規制当局の承認によりアクセシビリティが拡大し、短期的な体重減少に対するバルーンの有効性を裏付ける臨床エビデンスが信頼性を高めています。これらの要因が相まって、特に生活習慣に関連する健康問題が増加している都市部では、胃内バルーン市場の成長に有利な環境が整いつつあります。

米国では、新しいデザインの胃内バルーンシステムが非外科的減量法を進展させています。時間を定めて収縮し、自然に排泄される嚥下可能なカプセルは、利便性と安全性を高めています。知的財産の保護が今後10年間に拡大するにつれ、このような技術革新は、より広範な使用と臨床的受容の舞台を整えつつあります。例えば、2025年4月、リシェイプ・ライフサイエンス社は、胃内バルーン特許（出願18/241,151）についてUSPTOから許可通知を受領しました。この特許は、自己密封式の充填弁と分解可能な放出弁を備えた嚥下可能なカプセルを対象としており、3ヶ月後に収縮して自然に排泄されるように設計されています。このシステムは、非外科的減量ソリューションに革新をもたらします。特許が発行されれば、少なくとも2031年1月まで保護されます。

胃内バルーン市場動向

非外科的減量代替療法への需要の高まり

胃内バルーン市場の展望は、体重に関連する健康問題の広がりにより、非侵襲的治療への関心が高まっており、引き続き明るい展望です。胃内バルーンは、手術をせずに医療的に管理された減量を求める人々に好まれる選択肢になりつつあります。胃内バルーンは、手術を行わずに医療的な管理下で減量することを求める人々にとって、好ましい選択肢となりつつあります。これらの器具は、可逆的で集中的ではないアプローチを提供し、長い回復期間や永続的な解剖学的変化を避けることを目的とする患者と臨床医の両方にアピールするものです。また、医療的指導の下で、これらの手技をライフスタイルの変更と統合できることも魅力です。ヘルスケアシステムが肥満関連疾患の管理に対するプレッシャーの高まりに直面する中、安全で効果的かつコスト意識の高い早期介入方法がより重視されるようになっています。特に先進的外科治療へのアクセスが限られている地域では、啓発キャンペーンや医療界における幅広い受容が、採用をさらに後押ししています。世界保健機関（WHO）の報告によると、2022年には18歳以上の成人25億人が太りすぎで、そのうち8億9,000万人が肥満と共存しています。

体重管理における低侵襲手術へのシフト

臨床の嗜好は、従来型開腹手術から、より低侵襲な方法へと着実に移行しています。より小さな切開、より短い入院期間、より早い回復時間を必要とする処置が、開業医と患者の双方から支持を集めています。胃内バルーンの市場予測によると、このシフトは、安全性、利便性、術後合併症の減少を好む、体重関連の介入方法における広範な変化を反映しています。胃内バルーンはこの動きにうまく適合し、低リスクの解決策を求める患者の要望に沿った一時的で非外科的な選択肢を記載しています。より多くの医療従事者が低侵襲的アプローチを採用するにつれ、患者の快適さと外来治療モデルを優先する臨床現場では、このような機器が広く使用されるようになってきています。韓国で最近行われた調査では、開腹手術から低侵襲手技へのシフトが見られました。開腹手術の割合は、2014年の49.8％から2019年には27.6％に低下しました。

非外科的減量器具の検証の高まり

臨床研究は、非外科的減量オプションへの信頼を強めています。胃内バルーンは、ライフスタイルプログラムとともに有意義な結果をもたらす能力で注目を集めています。最近の検査データでは、長期にわたる持続的な体重減少と良好な安全性プロファイルが強調されており、手術に代わる選択肢を求める患者への幅広い使用が支持されています。これらの知見は医師の判断に影響を与え、より広範な採用のための規制の道筋を形成する可能性があります。最小限のリスクで測定可能な結果をもたらす治療法、特に体系化された生活習慣のサポートと組み合わせた治療法に対する関心は高まり続けています。より侵襲の少ない方法へのシフトは、臨床現場においても患者の嗜好においても顕著になってきています。これは、安全性、利便性、長期的効果に焦点を当てた、より広範な胃内バルーン市場動向を反映しています。例えば、2025年1月、Allurion Technologiesは、Allurion Balloonに関するFDAの主要検査であるAUDACITY検査のトップライン結果を報告しました。550人以上が参加し、バルーン2サイクルまたは生活習慣療法を受けた。48週時点で、バルーン投与者の58％が体重を5％以上減少させました。対照群に対する体重減少の差（3.77％）は、統計的には3％の優越性のマージンを逃したも、40週目にはマージンを上回りました。重篤な有害事象は3.1％と低く推移しました。

北米
- 米国
- カナダ
アジア太平洋
- 中国
- 日本
- インド
- 韓国
- オーストラリア
- インドネシア
- その他
欧州
- ドイツ
- フランス
- 英国
- イタリア
- スペイン
- ロシア
- その他
ラテンアメリカ
- ブラジル
- メキシコ
- その他
中東・アフリカ

第12章 SWOT分析

第13章バリューチェーン分析

第14章ポーターのファイブフォース分析

第15章価格指標

第16章競合情勢

市場構造
主要企業
主要企業のプロファイル
- Apollo Endosurgery
- Obalon Therapeutics Inc.
- ReShape Medical Inc.
- Medicone
- Medsil
- Allurion Technologies Inc.
- Helioscopie
- Spatz Fgia Inc.
- PlenSat
- Districlass Medical SA
- Endalis
- Lexel SRL
- Silimed Inc.
- Shandong Institute of Medical Instruments

図表

List of Figures

Figure 1: Global: Intragastric Balloons Market: Major Drivers and Challenges
Figure 2: Global: Intragastric Balloons Market: Sales Value (in Million USD), 2019-2024
Figure 3: Global: Intragastric Balloons Market: Breakup by Product (in %), 2024
Figure 4: Global: Intragastric Balloons Market: Breakup by Filling Material (in %), 2024
Figure 5: Global: Intragastric Balloons Market: Breakup by Implanting Procedure (in %), 2024
Figure 6: Global: Intragastric Balloons Market: Breakup by Application (in %), 2024
Figure 7: Global: Intragastric Balloons Market: Breakup by End-User (in %), 2024
Figure 8: Global: Intragastric Balloons Market: Breakup by Region (in %), 2024
Figure 9: Global: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 10: Global: Intragastric Balloons (Single Intragastric Balloon) Market: Sales Value (in Million USD), 2019 & 2024
Figure 11: Global: Intragastric Balloons (Single Intragastric Balloon) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 12: Global: Intragastric Balloons (Double Intragastric Balloon) Market: Sales Value (in Million USD), 2019 & 2024
Figure 13: Global: Intragastric Balloons (Double Intragastric Balloon) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 14: Global: Intragastric Balloons (Triple Intragastric Balloon) Market: Sales Value (in Million USD), 2019 & 2024
Figure 15: Global: Intragastric Balloons (Triple Intragastric Balloon) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 16: Global: Intragastric Balloons (Saline Filling) Market: Sales Value (in Million USD), 2019 & 2024
Figure 17: Global: Intragastric Balloons (Saline Filling) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 18: Global: Intragastric Balloons (Gas Filling) Market: Sales Value (in Million USD), 2019 & 2024
Figure 19: Global: Intragastric Balloons (Gas Filling) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 20: Global: Intragastric Balloons (Surgical Implant) Market: Sales Value (in Million USD), 2019 & 2024
Figure 21: Global: Intragastric Balloons (Surgical Implant) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 22: Global: Intragastric Balloons (Non-Surgical Implant) Market: Sales Value (in Million USD), 2019 & 2024
Figure 23: Global: Intragastric Balloons (Non-Surgical Implant) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 24: Global: Intragastric Balloons (Obesity) Market: Sales Value (in Million USD), 2019 & 2024
Figure 25: Global: Intragastric Balloons (Obesity) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 26: Global: Intragastric Balloons (Diabetes) Market: Sales Value (in Million USD), 2019 & 2024
Figure 27: Global: Intragastric Balloons (Diabetes) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 28: Global: Intragastric Balloons (Diet Control) Market: Sales Value (in Million USD), 2019 & 2024
Figure 29: Global: Intragastric Balloons (Diet Control) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 30: Global: Intragastric Balloons (Weight-Loss) Market: Sales Value (in Million USD), 2019 & 2024
Figure 31: Global: Intragastric Balloons (Weight-Loss) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 32: Global: Intragastric Balloons (Pre-Operative Weight Reduction) Market: Sales Value (in Million USD), 2019 & 2024
Figure 33: Global: Intragastric Balloons (Pre-Operative Weight Reduction) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 34: Global: Intragastric Balloons (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
Figure 35: Global: Intragastric Balloons (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 36: Global: Intragastric Balloons (Hospitals and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 37: Global: Intragastric Balloons (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 38: Global: Intragastric Balloons (Ambulatory Surgical Centers) Market: Sales Value (in Million USD), 2019 & 2024
Figure 39: Global: Intragastric Balloons (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 40: Global: Intragastric Balloons (Others) Market: Sales Value (in Million USD), 2019 & 2024
Figure 41: Global: Intragastric Balloons (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 42: North America: Intragastric Balloons Market: Sales Value (in Million USD), 2019 & 2024
Figure 43: North America: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 44: United States: Intragastric Balloons Market: Sales Value (in Million USD), 2019 & 2024
Figure 45: United States: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 46: Canada: Intragastric Balloons Market: Sales Value (in Million USD), 2019 & 2024
Figure 47: Canada: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 48: Asia Pacific: Intragastric Balloons Market: Sales Value (in Million USD), 2019 & 2024
Figure 49: Asia Pacific: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 50: China: Intragastric Balloons Market: Sales Value (in Million USD), 2019 & 2024
Figure 51: China: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 52: Japan: Intragastric Balloons Market: Sales Value (in Million USD), 2019 & 2024
Figure 53: Japan: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 54: India: Intragastric Balloons Market: Sales Value (in Million USD), 2019 & 2024
Figure 55: India: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 56: South Korea: Intragastric Balloons Market: Sales Value (in Million USD), 2019 & 2024
Figure 57: South Korea: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 58: Australia: Intragastric Balloons Market: Sales Value (in Million USD), 2019 & 2024
Figure 59: Australia: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 60: Indonesia: Intragastric Balloons Market: Sales Value (in Million USD), 2019 & 2024
Figure 61: Indonesia: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 62: Others: Intragastric Balloons Market: Sales Value (in Million USD), 2019 & 2024
Figure 63: Others: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 64: Europe: Intragastric Balloons Market: Sales Value (in Million USD), 2019 & 2024
Figure 65: Europe: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 66: Germany: Intragastric Balloons Market: Sales Value (in Million USD), 2019 & 2024
Figure 67: Germany: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 68: France: Intragastric Balloons Market: Sales Value (in Million USD), 2019 & 2024
Figure 69: France: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 70: United Kingdom: Intragastric Balloons Market: Sales Value (in Million USD), 2019 & 2024
Figure 71: United Kingdom: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 72: Italy: Intragastric Balloons Market: Sales Value (in Million USD), 2019 & 2024
Figure 73: Italy: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 74: Spain: Intragastric Balloons Market: Sales Value (in Million USD), 2019 & 2024
Figure 75: Spain: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 76: Russia: Intragastric Balloons Market: Sales Value (in Million USD), 2019 & 2024
Figure 77: Russia: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 78: Others: Intragastric Balloons Market: Sales Value (in Million USD), 2019 & 2024
Figure 79: Others: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 80: Latin America: Intragastric Balloons Market: Sales Value (in Million USD), 2019 & 2024
Figure 81: Latin America: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 82: Brazil: Intragastric Balloons Market: Sales Value (in Million USD), 2019 & 2024
Figure 83: Brazil: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 84: Mexico: Intragastric Balloons Market: Sales Value (in Million USD), 2019 & 2024
Figure 85: Mexico: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 86: Others: Intragastric Balloons Market: Sales Value (in Million USD), 2019 & 2024
Figure 87: Others: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 88: Middle East and Africa: Intragastric Balloons Market: Sales Value (in Million USD), 2019 & 2024
Figure 89: Middle East and Africa: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 90: Global: Intragastric Balloons Industry: SWOT Analysis
Figure 91: Global: Intragastric Balloons Industry: Value Chain Analysis
Figure 92: Global: Intragastric Balloons Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Intragastric Balloons Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Intragastric Balloons Market Forecast: Breakup by Product (in Million USD), 2025-2033
Table 3: Global: Intragastric Balloons Market Forecast: Breakup by Filling Material (in Million USD), 2025-2033
Table 4: Global: Intragastric Balloons Market Forecast: Breakup by Implanting Procedure (in Million USD), 2025-2033
Table 5: Global: Intragastric Balloons Market Forecast: Breakup by Application (in Million USD), 2025-2033
Table 6: Global: Intragastric Balloons Market Forecast: Breakup by End-User (in Million USD), 2025-2033
Table 7: Global: Intragastric Balloons Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 8: Global: Intragastric Balloons Market: Competitive Structure
Table 9: Global: Intragastric Balloons Market: Key Players

Product Code: SR112025A2085

The global intragastric balloons market size was valued at USD 70.19 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 169.63 Million by 2033, exhibiting a CAGR of 9.79% during 2025-2033. North America dominated the market in 2024. High obesity rates, advanced healthcare, early FDA approvals, and growing demand for non-surgical weight loss are some of the factors contributing to the intragastric balloons market share.

The market is gaining traction due to increasing global obesity rates and rising health concerns linked to excess weight. These balloons offer a non-surgical, temporary weight loss solution, appealing to patients seeking alternatives to invasive procedures. Growing awareness through digital health campaigns and recommendations by healthcare providers has further boosted demand. Technological improvements, such as swallowable, gas-filled, or adjustable balloons, enhance patient comfort and broaden eligibility. Additionally, supportive insurance policies in some countries and the growth of medical tourism, particularly in regions offering affordable endoscopic procedures, are driving adoption. Regulatory approvals across new markets are expanding accessibility, and clinical evidence supporting balloon effectiveness for short-term weight loss adds to their credibility. Combined, these factors create a favorable environment for intragastric balloons market growth, especially in urban areas with rising lifestyle-related health issues.

In the United States, new designs in intragastric balloon systems are advancing non-surgical weight loss methods. A swallowable capsule with timed deflation and natural excretion introduces added convenience and safety. As intellectual property protections extend into the next decade, such innovations are setting the stage for broader use and clinical acceptance. For instance, in April 2025, ReShape Lifesciences received a Notice of Allowance from the USPTO for its intragastric balloon patent (application 18/241,151). The patent covers a swallowable capsule with a self-sealing fill valve and a degradable release valve, designed to deflate after three months and be naturally excreted. This system adds innovation to non-surgical weight loss solutions. The patent, once issued, offers protection through at least January 2031.

Intragastric Balloons Market Trends:

Growing Demand for Non-Surgical Weight Loss Alternatives

The intragastric balloons market outlook remains positive as widespread weight-related health issues are pushing interest in non-invasive treatments. Intragastric balloons are becoming a preferred option for those seeking medically supervised weight loss without surgery. These devices offer a reversible and less intensive approach, which appeals to both patients and clinicians aiming to avoid long recovery periods or permanent anatomical changes. The appeal also lies in the ability to integrate these procedures with lifestyle changes under medical guidance. As healthcare systems face mounting pressure to manage obesity-related conditions, there's a stronger emphasis on early intervention methods that are safe, effective, and cost-conscious. Awareness campaigns and broader acceptance within medical communities are further reinforcing adoption, especially in regions with limited access to advanced surgical care. The World Health Organization (WHO) reported that in 2022, 2.5 Billion adults aged 18 and above were overweight, with 890 Million of them living with obesity.

Shift toward Minimally Invasive Procedures in Weight Management

Clinical preferences are steadily moving away from traditional open surgery in favor of less invasive methods. Procedures that require smaller incisions, shorter hospital stays, and quicker recovery times are gaining favor among both practitioners and patients. Based on the intragastric balloons market forecast, this shift reflects a broader change in how weight-related interventions are approached, favoring safety, convenience, and reduced post-operative complications. Intragastric balloons fit neatly into this movement, offering a temporary, non-surgical option that aligns with patient demand for low-risk solutions. As more medical professionals adopt minimally invasive approaches, devices like these are seeing wider use in clinical settings that prioritize patient comfort and outpatient care models. A recent survey in Korea showed a shift from open surgery to minimally invasive techniques. The rate of open surgery dropped from 49.8% in 2014 to 27.6% in 2019.

Increased Validation of Non-Surgical Weight Loss Devices

Clinical studies are reinforcing confidence in non-surgical weight loss options. Intragastric balloons are drawing attention for their ability to deliver meaningful results alongside lifestyle programs. Recent trial data highlights sustained weight reduction over time with a favorable safety profile, supporting wider use in patients seeking alternatives to surgery. These findings are influencing physician decisions and could shape regulatory pathways for broader adoption. Interest continues to grow in treatments that offer measurable outcomes with minimal risk, especially when combined with structured lifestyle support. The shift toward less invasive methods is becoming more pronounced in clinical practice and patient preference alike. This reflects broader intragastric balloons market trends focused on safety, convenience, and long-term effectiveness. For example, in January 2025, Allurion Technologies reported topline results from its FDA pivotal AUDACITY trial on the Allurion Balloon. Over 550 participants joined, receiving two balloon cycles or lifestyle therapy. At 48 weeks, 58% of balloon recipients lost over 5% of body weight. Though the weight loss difference vs. controls (3.77%) missed the 3% superiority margin statistically, the margin was exceeded at 40 weeks. Serious adverse events were low at 3.1%.

Intragastric Balloons Industry Segmentation:

Analysis by Product:

Single Intragastric Balloon
Double Intragastric Balloon
Triple Intragastric Balloon

Single intragastric balloon stood as the largest product in 2024. This type of balloon is gaining traction due to its simpler placement procedure, lower cost compared to dual or adjustable variants, and fewer associated complications. It's usually inserted endoscopically and removed after six months, offering a less invasive alternative to bariatric surgery for short-term weight loss. Patients and clinicians often prefer this option for its safety profile, faster recovery, and minimal maintenance. As obesity rates climb and demand grows for non-surgical weight loss methods, single-balloon systems are seeing wider adoption across clinics. Their convenience and growing clinical acceptance make them a leading contributor to market expansion.

Analysis by Filling Material:

Saline Filling
Gas Filling

Saline filling led the market in 2024. These balloons are filled with sterile saline solution after placement in the stomach, making them safer and more widely accepted. Saline allows easy visualization on imaging, which helps in monitoring and ensures prompt response to any deflation. They also come with a blue dye indicator; if leakage occurs, the dye colors the urine, acting as an early warning system. This safety feature, combined with affordability and a long track record of clinical use, makes saline-filled balloons more appealing than gas-filled options. Their predictable performance and broader physician preference are accelerating their adoption, especially in outpatient settings and emerging markets where cost and reliability are key factors.

Analysis by Implanting Procedure:

Surgical
Non-Surgical

Non-surgical led the market in 2024 as more patients seek weight loss solutions that avoid the risks, recovery time, and cost of surgery. Intragastric balloons offer a minimally invasive approach, typically placed and removed via endoscopy or swallowed in capsule form, making them accessible to a wider population, including those who are not candidates for bariatric surgery. This appeals to individuals looking for a temporary, reversible option with fewer complications. Clinics and providers are also expanding their offerings to include non-surgical procedures to meet rising demand. The growing interest in outpatient and office-based treatments further supports this trend. Convenience, safety, and faster return to daily activities are making the non-surgical segment a key growth driver in this market.

Analysis by Application:

Obesity
Diabetes
Diet Control
Weight-Loss
Pre-Operative Weight Reduction
Others

Obesity led the market in 2024. With global obesity rates climbing steadily, more individuals are seeking effective weight management options beyond diet and exercise. Intragastric balloons offer a non-permanent, non-surgical intervention that supports initial weight loss and motivates lifestyle change. They are especially useful for patients with moderate obesity who may not qualify for bariatric surgery but still need medical intervention. As obesity is linked to conditions like diabetes, hypertension, and heart disease, healthcare providers are recommending earlier weight management strategies, including balloons. Rising awareness, insurance coverage improvements, and government health initiatives targeting obesity are also contributing to increased adoption, making the obesity segment a strong driver of market growth.

Analysis by End-User:

Hospitals and Clinics
Ambulatory Surgical Centers
Others

Hospitals and clinics led the market in 2024, owing to their access to trained gastroenterologists, advanced endoscopic equipment, and post-procedure care. These settings are preferred for balloon placement and removal because they offer higher safety standards, patient monitoring, and comprehensive weight management programs. As awareness grows, more patients are turning to hospitals and specialty clinics for non-surgical obesity treatments. The rise in outpatient services and day-care procedures has made balloon insertion more convenient and cost-effective in these environments. Additionally, hospitals often partner with wellness programs and dieticians, offering patients a full treatment path. Their credibility, infrastructure, and capacity to handle complications make hospitals and clinics the go-to centers, boosting the segment's impact on market expansion.

Regional Analysis:

North America
- United States
- Canada
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

In 2024, North America accounted for the largest market share. The region has one of the highest obesity rates globally, creating strong demand for effective, non-surgical weight-loss solutions. The presence of advanced healthcare infrastructure and well-established medical facilities enables widespread adoption of intragastric balloon procedures. Additionally, North America benefits from early regulatory approvals by agencies like the FDA, allowing quicker market access for innovative devices. High awareness levels among patients and healthcare professionals, along with strong marketing efforts by key manufacturers, also contribute to regional growth. Insurance coverage and reimbursement options in some areas further support patient access. Moreover, a growing preference for outpatient and minimally invasive procedures aligns well with balloon treatments. These combined factors continue to strengthen North America's leading position in the global intragastric balloons market.

Key Regional Takeaways:

United States Intragastric Balloons Market Analysis

The United States intragastric balloons market is primarily driven by the rising prevalence of obesity and related health complications. According to the new 2023 CDC population data, over one in three adults (35%) in 23 states are affected by obesity. Also, at least one in five adults (20%) in every U.S. state is currently living with obesity. In line with this, continual advances in balloon technology have significantly improved the safety and efficacy of procedures, attracting more patients to the market. The increasing awareness of non-surgical weight loss options is further driving market growth as individuals seek alternatives to traditional surgical procedures. Similarly, the growing preference for minimally invasive procedures, offering faster recovery times, is also fueling market demand. Furthermore, the heightened emphasis on preventive healthcare, motivating people to manage their weight actively, is fostering market expansion. Additionally, the rising trend of medical tourism is contributing to the market appeal as patients seek cost-effective solutions abroad. Moreover, favorable government initiatives and policies focused on obesity management are creating a supportive environment for market development, accelerating the adoption of intragastric balloon treatments.

Europe Intragastric Balloons Market Analysis

The market for intragastric balloons in Europe is experiencing growth due to the increasing prevalence of obesity and related chronic conditions. In accordance with this, the growing awareness of non-surgical weight loss options is encouraging patients to opt for minimally invasive treatments. Furthermore, ongoing advancements in intragastric balloon technology, which offers improved safety and effectiveness, are enhancing market appeal. The rise of medical tourism in Europe, where patients seek cost-effective solutions, is also contributing to market expansion. Additionally, supportive healthcare policies and reimbursement schemes across European countries are improving access to these treatments. The aging population in Europe, more prone to obesity, is another key market driver. The 2022 Health Survey for England found that individuals aged 55 to 74 were more likely to be overweight or obese compared to other age groups, with over 70% of people in these age ranges having excess weight. Additionally, preventive healthcare initiatives and a growing focus on wellness are fueling demand for weight management solutions. Apart from this, numerous collaborations between healthcare providers and research institutions are fostering innovation, further impacting market trends.

Asia Pacific Intragastric Balloons Market Analysis

The Asia Pacific market is predominantly driven by rapid urbanization and changing dietary habits, resulting in a larger patient base. In addition to this, growing awareness of minimally invasive procedures is prompting more individuals to opt for intragastric balloons as a non-surgical option. Furthermore, supportive government initiatives focusing on obesity management and preventive healthcare are fostering market growth. The region's increasing access to advanced medical technologies, which enhance the safety and effectiveness of treatments, is strengthening the market demand. Moreover, the expanding middle class, with higher disposable incomes, is fueling demand for weight loss treatments, providing further market potential. According to the People Research on India's Consumer Economy (PRICE), India's middle class is the fastest-growing segment, expanding at a rate of 6.3% annually, with an increase of 338 Million people from 1995 to 2021. It now constitutes 31% of the population and is projected to reach 38% by 2031 and 60% by 2047.

Latin America Intragastric Balloons Market Analysis

In Latin America, the market for intragastric balloons is expanding, predominantly driven by rising disposable income, which enables more individuals to afford weight loss treatments. Similarly, increasing awareness of minimally invasive procedures is encouraging individuals to opt for non-surgical options. The growing availability of advanced medical technologies, enhancing the safety and efficacy of treatments, is further fueling market expansion. Moreover, favorable government initiatives focused on addressing obesity through public health campaigns and improving healthcare access are making these treatments more accessible, strengthening the market's presence. As such, Novo Nordisk planned to invest USD 1.09 Billion in Brazil to expand production of Ozempic, Wegovy, and other injectable drugs. The investment will enhance manufacturing capacity at its Minas Gerais facility, with operations set to begin in 2028.

Middle East and Africa Intragastric Balloons Market Analysis

The market in the Middle East and Africa is significantly influenced by the growing awareness of obesity-related health risks and the need for effective weight loss solutions. The 2023 update from the World Obesity Federation's Global Observatory revealed that the UAE has a childhood obesity prevalence rate of 15% among girls (ranked 24th globally) and 18.5% among boys (ranked 21st globally). Furthermore, increasing access to modern medical treatments in the region, bolstered by investments in healthcare infrastructure, is accelerating market demand. Additionally, the region's growing health-conscious population, particularly among younger generations, is driving the need for minimally invasive weight loss options, thereby impelling the market. Moreover, various collaborative partnerships between local healthcare providers and global medical device companies are enhancing the availability and affordability of these treatments, providing an impetus to the market.

Competitive Landscape:

The intragastric balloon market is seeing steady activity with ongoing product launches, regulatory approvals, and research-driven innovation. Companies are introducing adjustable and non-invasive balloon systems to improve safety and patient comfort. Partnerships, mergers, and funding rounds are being used to expand product portfolios and global reach. Research institutions are contributing to the development of next-generation capsules with automated inflation features. While government initiatives mainly support obesity awareness and prevention, they indirectly benefit market growth. Among these, research and development, along with commercial partnerships, remain the most common practices, helping companies differentiate their offerings and meet regulatory requirements in new markets.

The report provides a comprehensive analysis of the competitive landscape in the intragastric balloons market with detailed profiles of all major companies, including:

Apollo Endosurgery
Obalon Therapeutics Inc.
ReShape Medical Inc.
Medicone
Medsil
Allurion Technologies Inc.
Helioscopie
Spatz Fgia Inc.
PlenSat
Districlass Medical SA
Endalis
Lexel SRL
Silimed Inc.
Shandong Institute of Medical Instruments

Key Questions Answered in This Report

1.How big is the intragastric balloons market?
2.What is the future outlook of intragastric balloons market?
3.What are the key factors driving the intragastric balloons market?
4.Which region accounts for the largest intragastric balloons market share?
5.Which are the leading companies in the global intragastric balloons market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Intragastric Balloons Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product

6.1 Single Intragastric Balloon
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Double Intragastric Balloon
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Triple Intragastric Balloon
- 6.3.1 Market Trends
- 6.3.2 Market Forecast

7 Market Breakup by Filling Material

7.1 Saline Filling
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Gas Filling
- 7.2.1 Market Trends
- 7.2.2 Market Forecast

8 Market Breakup by Implanting Procedure

8.1 Surgical
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Non-Surgical
- 8.2.1 Market Trends
- 8.2.2 Market Forecast

9 Market Breakup by Application

9.1 Obesity
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Diabetes
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Diet Control
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
9.4 Weight-Loss
- 9.4.1 Market Trends
- 9.4.2 Market Forecast
9.5 Pre-Operative Weight Reduction
- 9.5.1 Market Trends
- 9.5.2 Market Forecast
9.6 Others
- 9.6.1 Market Trends
- 9.6.2 Market Forecast

10 Market Breakup by End-User

10.1 Hospitals and Clinics
- 10.1.1 Market Trends
- 10.1.2 Market Forecast
10.2 Ambulatory Surgical Centers
- 10.2.1 Market Trends
- 10.2.2 Market Forecast
10.3 Others
- 10.3.1 Market Trends
- 10.3.2 Market Forecast

11 Market Breakup by Region

11.1 North America
- 11.1.1 United States
  - 11.1.1.1 Market Trends
  - 11.1.1.2 Market Forecast
- 11.1.2 Canada
  - 11.1.2.1 Market Trends
  - 11.1.2.2 Market Forecast
11.2 Asia Pacific
- 11.2.1 China
  - 11.2.1.1 Market Trends
  - 11.2.1.2 Market Forecast
- 11.2.2 Japan
  - 11.2.2.1 Market Trends
  - 11.2.2.2 Market Forecast
- 11.2.3 India
  - 11.2.3.1 Market Trends
  - 11.2.3.2 Market Forecast
- 11.2.4 South Korea
  - 11.2.4.1 Market Trends
  - 11.2.4.2 Market Forecast
- 11.2.5 Australia
  - 11.2.5.1 Market Trends
  - 11.2.5.2 Market Forecast
- 11.2.6 Indonesia
  - 11.2.6.1 Market Trends
  - 11.2.6.2 Market Forecast
- 11.2.7 Others
  - 11.2.7.1 Market Trends
  - 11.2.7.2 Market Forecast
11.3 Europe
- 11.3.1 Germany
  - 11.3.1.1 Market Trends
  - 11.3.1.2 Market Forecast
- 11.3.2 France
  - 11.3.2.1 Market Trends
  - 11.3.2.2 Market Forecast
- 11.3.3 United Kingdom
  - 11.3.3.1 Market Trends
  - 11.3.3.2 Market Forecast
- 11.3.4 Italy
  - 11.3.4.1 Market Trends
  - 11.3.4.2 Market Forecast
- 11.3.5 Spain
  - 11.3.5.1 Market Trends
  - 11.3.5.2 Market Forecast
- 11.3.6 Russia
  - 11.3.6.1 Market Trends
  - 11.3.6.2 Market Forecast
- 11.3.7 Others
  - 11.3.7.1 Market Trends
  - 11.3.7.2 Market Forecast
11.4 Latin America
- 11.4.1 Brazil
  - 11.4.1.1 Market Trends
  - 11.4.1.2 Market Forecast
- 11.4.2 Mexico
  - 11.4.2.1 Market Trends
  - 11.4.2.2 Market Forecast
- 11.4.3 Others
  - 11.4.3.1 Market Trends
  - 11.4.3.2 Market Forecast
11.5 Middle East and Africa
- 11.5.1 Market Trends
- 11.5.2 Market Breakup by Country
- 11.5.3 Market Forecast

12 SWOT Analysis

12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes

15 Price Indicators

16 Competitive Landscape

16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
- 16.3.1 Apollo Endosurgery
  - 16.3.1.1 Company Overview
  - 16.3.1.2 Product Portfolio
  - 16.3.1.3 Financials
  - 16.3.1.4 SWOT Analysis
- 16.3.2 Obalon Therapeutics Inc.
  - 16.3.2.1 Company Overview
  - 16.3.2.2 Product Portfolio
  - 16.3.2.3 Financials
- 16.3.3 ReShape Medical Inc.
  - 16.3.3.1 Company Overview
  - 16.3.3.2 Product Portfolio
- 16.3.4 Medicone
  - 16.3.4.1 Company Overview
  - 16.3.4.2 Product Portfolio
- 16.3.5 Medsil
  - 16.3.5.1 Company Overview
  - 16.3.5.2 Product Portfolio
- 16.3.6 Allurion Technologies Inc.
  - 16.3.6.1 Company Overview
  - 16.3.6.2 Product Portfolio
- 16.3.7 Helioscopie
  - 16.3.7.1 Company Overview
  - 16.3.7.2 Product Portfolio
- 16.3.8 Spatz Fgia Inc.
  - 16.3.8.1 Company Overview
  - 16.3.8.2 Product Portfolio
- 16.3.9 PlenSat
  - 16.3.9.1 Company Overview
  - 16.3.9.2 Product Portfolio
- 16.3.10 Districlass Medical SA
  - 16.3.10.1 Company Overview
  - 16.3.10.2 Product Portfolio
  - 16.3.10.3 Financials
- 16.3.11 Endalis
  - 16.3.11.1 Company Overview
  - 16.3.11.2 Product Portfolio
  - 16.3.11.3 Financials
- 16.3.12 Lexel SRL
  - 16.3.12.1 Company Overview
  - 16.3.12.2 Product Portfolio
  - 16.3.12.3 Financials
- 16.3.13 Silimed Inc.
  - 16.3.13.1 Company Overview
  - 16.3.13.2 Product Portfolio
- 16.3.14 Shandong Institute of Medical Instruments
  - 16.3.14.1 Company Overview
  - 16.3.14.2 Product Portfolio

胃内バルーン市場：2025～2033年：製品、充填材料、インプラント手術、用途、エンドユーザー、地域別市場規模、シェア、動向、予測

Intragastric Balloons Market Size, Share, Trends and Forecast by Product, Filling Material, Implanting Procedure, Application, End-User, and Region, 2025-2033

胃内バルーン市場動向

目次

第1章 序文

第2章 調査範囲と調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界の胃内バルーン市場

第6章 市場内訳：製品別

第7章 市場内訳：充填材別

第8章 市場内訳：インプラント手術別

第9章 市場内訳：用途別

第10章 市場内訳：エンドユーザー別

第11章 市場内訳：地域別

第12章 SWOT分析

第13章 バリューチェーン分析

第14章 ポーターのファイブフォース分析

第15章 価格指標

第16章 競合情勢